Last reviewed · How we verify

NCT05691933

Regional Block for Upper Abdominal Surgeries

Status unknown Phase 3 Last updated 25 January 2023
What this trial tests

Phase 3 trial testing Block group in Perioperative Analgesia in Major Upper Abdominal Surgery in 120 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
1 July 2023
1 July 2023

Quick facts

Lead sponsorAlexandria University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment120
Start date1 February 2023
Primary completion1 July 2023
Estimated completion1 July 2023

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

18 and older, any sex, with Perioperative Analgesia in Major Upper Abdominal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain control after major upper abdominal surgeries is an essential step to guard against postoperative complications such as lung atelectasis. This major step can be achieved by opioids or regional blocks. Regional blocks allow better pain control and avoid side effects of opioid based pain control

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Block group

Trials testing the same drug.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05691933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing